Literature DB >> 9559612

Effects of filter pore size on efficacy of continuous arteriovenous hemofiltration therapy for Staphylococcus aureus-induced septicemia in immature swine.

P A Lee1, G W Weger, R W Pryor, J R Matson.   

Abstract

OBJECTIVE: To evaluate the effect of hemofilter pore size on the efficacy of continuous arteriovenous hemofiltration (CAVH) in improving morbidity and mortality in an immature swine model of Staphylococcus aureus-induced septicemia.
DESIGN: Prospective, randomized study with age-matched controls.
SETTING: Biomedical research facility.
SUBJECTS: Fourteen 4 to 8-wk-old, weaned Poland-China swine, weighing 5 to 10 kg.
INTERVENTIONS: Spontaneously breathing, ketamine-sedated swine (4 to 8 wks of age) were given an intravenous lethal dose of live S. aureus. Animals were then filtered with either a 50-kilodalton (kD) pore size filter (control) or a 100-kD pore size filter (experimental). No animals received antibiotics.
MEASUREMENTS AND MAIN RESULTS: Physiologic, biochemical, and hematologic parameters were measured in all animals every 1 to 3 hrs. Animals were monitored continuously and survival time (hr) was recorded (permanent survival = 168 hrs/7 days). Animals filtered with the 100-kD filter survived significantly longer than control animals (103 +/- 18 [SEM] vs. 56 +/- 9 hrs). The 100-kD-filtered group had one permanent survivor (168 hrs). Protein concentration of the ultrafiltrate obtained from the 100-kD-filtered animals was eight-fold higher than control ultrafiltrate. The protein removed did not contain a high percentage of albumin (as determined by autoanalyzer methods). No significant differences were seen in any of the other measured parameters.
CONCLUSIONS: CAVH significantly improved survival in swine with S. aureus-induced sepsis. The superior performance of the 100-kD filter vs. the 50-kD filter suggests that higher molecular weight mediators that are not removed efficiently by the 50-kD filter may be responsible for the morbidity and mortality seen in this model of sepsis. These mediators may be removed in greater proportion by our customized (100-kD pore size) filter.

Entities:  

Mesh:

Year:  1998        PMID: 9559612     DOI: 10.1097/00003246-199804000-00024

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  9 in total

1.  Management of acute renal dysfunction in sepsis.

Authors:  Federico Nalesso; Zaccaria Ricci; Claudio Ronco
Journal:  Curr Infect Dis Rep       Date:  2012-10       Impact factor: 3.725

2.  Role of Therapeutic Plasmapheresis in SARS-CoV-2 Induced Cytokine Release Syndrome: A Retrospective Cohort Study on COVID-19 Patients.

Authors:  Zubia Jamil; Azmat Ali Khan; Hamid Yousuf; Kashaf Khalid; Shahid Mumtaz Abbasi; Yasir Waheed
Journal:  Int J Gen Med       Date:  2022-05-12

3.  Intermittent high permeability hemofiltration in septic patients with acute renal failure.

Authors:  Stanislao Morgera; Jens Rocktäschel; Michael Haase; Christian Lehmann; Christian von Heymann; Sabine Ziemer; Friedrich Priem; Berthold Hocher; Hermann Göhl; Wolfgang J Kox; Hans-W Buder; Hans-H Neumayer
Journal:  Intensive Care Med       Date:  2003-09-03       Impact factor: 17.440

Review 4.  Clinical review: blood purification for sepsis.

Authors:  Thomas Rimmelé; John A Kellum
Journal:  Crit Care       Date:  2011-02-16       Impact factor: 9.097

Review 5.  Continuous haemofiltration in the intensive care unit.

Authors:  R Bellomo; C Ronco
Journal:  Crit Care       Date:  2000-10-20       Impact factor: 9.097

Review 6.  Renal Replacement Therapy.

Authors:  Zaccaria Ricci; Stefano Romagnoli; Claudio Ronco
Journal:  F1000Res       Date:  2016-01-25

7.  Therapeutic plasma exchange for coronavirus disease-2019 triggered cytokine release syndrome; a retrospective propensity matched control study.

Authors:  Sultan Mehmood Kamran; Zill-E-Humayun Mirza; Arshad Naseem; Jahanzeb Liaqat; Imran Fazal; Wasim Alamgir; Farrukh Saeed; Salman Saleem; Shazia Nisar; Muhammad Ali Yousaf; Asad Zaman Khan; Mehmood Hussain; Rizwan Azam; Maryam Hussain; Kumail Abbas Khan; Yousaf Jamal; Raheel Iftikhar
Journal:  PLoS One       Date:  2021-01-07       Impact factor: 3.240

Review 8.  Hemofiltration, adsorption, sieving and the challenge of sepsis therapy design.

Authors:  Patrick M Honoré; James R Matson
Journal:  Crit Care       Date:  2002-09-04       Impact factor: 9.097

9.  Plasmadiafiltration ameliorating gut mucosal barrier dysfunction and improving survival in porcine sepsis models.

Authors:  Ming Xin Li; Jun Feng Liu; Jian Da Lu; Ying Zhu; Ding Wei Kuang; Jian Bing Xiang; Peng Sun; Wei Wang; Jun Xue; Yong Gu; Chuan Ming Hao
Journal:  Intensive Care Med Exp       Date:  2016-09-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.